Épisodes

  • Lilly Could Lose Their Tirzepatide Patent! Plus ADA Coverage // OTP TWD 06.24.25

    Lilly Could Lose Their Tirzepatide Patent! Plus ADA Coverage // OTP TWD 06.24.25
    Jun 24 2025

    Get Our Newsletter and Help us Grow!
    https://www.obesity.news

    Support OTP (all our links):
    https://linktr.ee/manonthemounjaro
    Voir plus Voir moins
    27 min
  • Faces of The Fight: The Jamie Selzler Story

    Faces of The Fight: The Jamie Selzler Story
    Jun 23 2025
    At 650 pounds, GLP-1 injections helped give Jamie His Life Back. Get Our Newsletter and Help us Grow! https://www.obesity.news Support OTP (all our links): https://linktr.ee/manonthemounjaro
    Voir plus Voir moins
    58 min
  • Zepbound Vials Drop, Amycretin Surges, FDA Fast Track, and a Dangerous Trend // TWD 6.17.25

    Zepbound Vials Drop, Amycretin Surges, FDA Fast Track, and a Dangerous Trend // TWD 6.17.25
    Jun 17 2025

    SUPPORT OUR WORK AND GET MORE NEWS!
    https://linktr.ee/manonthemounjaro
    Voir plus Voir moins
    30 min
  • GLP-1 Access Progress + The Race for Less Frequent Dosing: OTP TWD 6.10.25

    GLP-1 Access Progress + The Race for Less Frequent Dosing: OTP TWD 6.10.25
    Jun 10 2025
    https://www.linktr.ee/manonthemounjaro Ozempic rare eye disease update The the race for once monthly dosing Big insurance wins incoming?!
    Voir plus Voir moins
    23 min
  • Lilly Makes Bold Move on GLP Dosing / 8x More Ozempic? / Wegovy Use in Teens

    Lilly Makes Bold Move on GLP Dosing / 8x More Ozempic? / Wegovy Use in Teens
    Jun 3 2025

    VIEW ALL OF OUR LINKS: https://linktr.ee/manonthemounjaro
    JOIN OUR SUBSTACK: HTTP://WWW.ONTHEPEN.SUBSTACK.COM
    Voir plus Voir moins
    21 min
  • Trump Admin Setting Price Targets for Zepbound and Ozempic, Will Pharma Go Along?

    Trump Admin Setting Price Targets for Zepbound and Ozempic, Will Pharma Go Along?
    May 20 2025

    Join the Substack here: onthepen.substack.com
    Get all my links here: https://linktr.ee/manonthemounjaro
    Voir plus Voir moins
    30 min
  • Zepbound vs. Wegovy, CVS vs. Patients, and the Executive Order That Changes Everything

    Zepbound vs. Wegovy, CVS vs. Patients, and the Executive Order That Changes Everything
    May 13 2025

    Joe's Petition + All My Links:
    https://linktr.ee/manonthemounjaro
    Voir plus Voir moins
    41 min
  • Compound Tirzepatide Lawsuit + PBM Reform Update // OTP TWD 5.6.25

    Compound Tirzepatide Lawsuit + PBM Reform Update // OTP TWD 5.6.25
    May 6 2025

    Dave discussed the latest update in the OFA vs FDA compound tirzepatide battle, as well as this weeks news in obesity medicine.

    Find our substack and all promotional links here:
    https://linktr.ee/manonthemounjaro
    Voir plus Voir moins
    27 min